Assessment of the role of surgery for stage III bronchogenic carcinoma
In order to assess the role of surgery for stage III bronchogenic carcinoma, we reviewed our results of 282 patients who were treated with surgical resection or various other therapy modalities. The survival in patients who underwent surgical resection was significantly better than those with nonres...
Gespeichert in:
| Veröffentlicht in: | Journal of surgical oncology 1984-03, Vol.25 (3), p.153-158 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 158 |
|---|---|
| container_issue | 3 |
| container_start_page | 153 |
| container_title | Journal of surgical oncology |
| container_volume | 25 |
| creator | Hara, Nobuyuki Ohta, Mitsuo Tanaka, Koichi Ichinose, Yukihito Noge, Sazahito Miyazaki, Kazuhiro Ishimatsu, Toyohiro |
| description | In order to assess the role of surgery for stage III bronchogenic carcinoma, we reviewed our results of 282 patients who were treated with surgical resection or various other therapy modalities. The survival in patients who underwent surgical resection was significantly better than those with nonresectable carcinoma. However, superior survival results were demonstrated only in patients with complete resection. In contrast, the survival in patients with palliative resection was similar to that in patients with exploratory thoracotomy and inoperable carcinoma. On the other hand, all patients with T3N2 lesions died of their disease within two years after surgery even when undergoing complete resection. Thus, we conclude that radical resection should be indicated in patients with T3N0–1 and Tl–2N2 lesions if complete resection is expected. |
| doi_str_mv | 10.1002/jso.2930250304 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80984584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80984584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4074-38d12fd31c535a208b8e0cb7ef3b92a21204364110fcfc4ac9976d4159b53aa13</originalsourceid><addsrcrecordid>eNqFkMtPGzEQxq0KBIH22lulPaDeNowf-_ARIQKpaHNIK46W1xmHhd019WxU8t9jlChVTz3NJ83vm8fH2GcOUw4gLp8oTIWWIAqQoD6wCQdd5hp0fcQmCRC5qjScsjOiJwDQulQn7KTkSQg-YbMrIiTqcRiz4LPxEbMYOnzXtIlrjNvMh5jRaNeYzefzrIlhcI9hjUPrMmeja4fQ24_s2NuO8NO-nrNfs5uf13f5_eJ2fn11nzsFlcplveLCryR3hSysgLqpEVxToZeNFlZwAUqWinPwzjtlndZVuVK80E0hreXynH3dzX2J4fcGaTR9Sw67zg4YNmTq9LcqapXA6Q50MRBF9OYltr2NW8PBvAdnUnDmb3DJ8GU_edP0uDrg-6RS_2Lft-Rs56MdXEsHLDGq0HXC9A7703a4_c9S8225-OeEfOdtacTXg9fGZ1NWsirMw49bM4MHob4vawPyDV_UlFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80984584</pqid></control><display><type>article</type><title>Assessment of the role of surgery for stage III bronchogenic carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hara, Nobuyuki ; Ohta, Mitsuo ; Tanaka, Koichi ; Ichinose, Yukihito ; Noge, Sazahito ; Miyazaki, Kazuhiro ; Ishimatsu, Toyohiro</creator><creatorcontrib>Hara, Nobuyuki ; Ohta, Mitsuo ; Tanaka, Koichi ; Ichinose, Yukihito ; Noge, Sazahito ; Miyazaki, Kazuhiro ; Ishimatsu, Toyohiro</creatorcontrib><description>In order to assess the role of surgery for stage III bronchogenic carcinoma, we reviewed our results of 282 patients who were treated with surgical resection or various other therapy modalities. The survival in patients who underwent surgical resection was significantly better than those with nonresectable carcinoma. However, superior survival results were demonstrated only in patients with complete resection. In contrast, the survival in patients with palliative resection was similar to that in patients with exploratory thoracotomy and inoperable carcinoma. On the other hand, all patients with T3N2 lesions died of their disease within two years after surgery even when undergoing complete resection. Thus, we conclude that radical resection should be indicated in patients with T3N0–1 and Tl–2N2 lesions if complete resection is expected.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.2930250304</identifier><identifier>PMID: 6199621</identifier><identifier>CODEN: JSONAU</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adenocarcinoma - mortality ; Adenocarcinoma - surgery ; Biological and medical sciences ; Carcinoma, Bronchogenic - mortality ; Carcinoma, Bronchogenic - surgery ; Carcinoma, Small Cell - mortality ; Carcinoma, Small Cell - surgery ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - surgery ; Combined Modality Therapy ; complete resection ; exploratory thoracotomy ; Humans ; inoperable carcinoma ; Lung Neoplasms - mortality ; Lung Neoplasms - surgery ; Medical sciences ; Palliative Care ; palliative resection ; Pneumology ; Pneumonectomy ; Prognosis ; stage III bronchogenic carcinoma ; Tumors of the respiratory system and mediastinum</subject><ispartof>Journal of surgical oncology, 1984-03, Vol.25 (3), p.153-158</ispartof><rights>Copyright © 1984 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4074-38d12fd31c535a208b8e0cb7ef3b92a21204364110fcfc4ac9976d4159b53aa13</citedby><cites>FETCH-LOGICAL-c4074-38d12fd31c535a208b8e0cb7ef3b92a21204364110fcfc4ac9976d4159b53aa13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjso.2930250304$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjso.2930250304$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9624598$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6199621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hara, Nobuyuki</creatorcontrib><creatorcontrib>Ohta, Mitsuo</creatorcontrib><creatorcontrib>Tanaka, Koichi</creatorcontrib><creatorcontrib>Ichinose, Yukihito</creatorcontrib><creatorcontrib>Noge, Sazahito</creatorcontrib><creatorcontrib>Miyazaki, Kazuhiro</creatorcontrib><creatorcontrib>Ishimatsu, Toyohiro</creatorcontrib><title>Assessment of the role of surgery for stage III bronchogenic carcinoma</title><title>Journal of surgical oncology</title><addtitle>J. Surg. Oncol</addtitle><description>In order to assess the role of surgery for stage III bronchogenic carcinoma, we reviewed our results of 282 patients who were treated with surgical resection or various other therapy modalities. The survival in patients who underwent surgical resection was significantly better than those with nonresectable carcinoma. However, superior survival results were demonstrated only in patients with complete resection. In contrast, the survival in patients with palliative resection was similar to that in patients with exploratory thoracotomy and inoperable carcinoma. On the other hand, all patients with T3N2 lesions died of their disease within two years after surgery even when undergoing complete resection. Thus, we conclude that radical resection should be indicated in patients with T3N0–1 and Tl–2N2 lesions if complete resection is expected.</description><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - surgery</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Bronchogenic - mortality</subject><subject>Carcinoma, Bronchogenic - surgery</subject><subject>Carcinoma, Small Cell - mortality</subject><subject>Carcinoma, Small Cell - surgery</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Combined Modality Therapy</subject><subject>complete resection</subject><subject>exploratory thoracotomy</subject><subject>Humans</subject><subject>inoperable carcinoma</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - surgery</subject><subject>Medical sciences</subject><subject>Palliative Care</subject><subject>palliative resection</subject><subject>Pneumology</subject><subject>Pneumonectomy</subject><subject>Prognosis</subject><subject>stage III bronchogenic carcinoma</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtPGzEQxq0KBIH22lulPaDeNowf-_ARIQKpaHNIK46W1xmHhd019WxU8t9jlChVTz3NJ83vm8fH2GcOUw4gLp8oTIWWIAqQoD6wCQdd5hp0fcQmCRC5qjScsjOiJwDQulQn7KTkSQg-YbMrIiTqcRiz4LPxEbMYOnzXtIlrjNvMh5jRaNeYzefzrIlhcI9hjUPrMmeja4fQ24_s2NuO8NO-nrNfs5uf13f5_eJ2fn11nzsFlcplveLCryR3hSysgLqpEVxToZeNFlZwAUqWinPwzjtlndZVuVK80E0hreXynH3dzX2J4fcGaTR9Sw67zg4YNmTq9LcqapXA6Q50MRBF9OYltr2NW8PBvAdnUnDmb3DJ8GU_edP0uDrg-6RS_2Lft-Rs56MdXEsHLDGq0HXC9A7703a4_c9S8225-OeEfOdtacTXg9fGZ1NWsirMw49bM4MHob4vawPyDV_UlFY</recordid><startdate>198403</startdate><enddate>198403</enddate><creator>Hara, Nobuyuki</creator><creator>Ohta, Mitsuo</creator><creator>Tanaka, Koichi</creator><creator>Ichinose, Yukihito</creator><creator>Noge, Sazahito</creator><creator>Miyazaki, Kazuhiro</creator><creator>Ishimatsu, Toyohiro</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198403</creationdate><title>Assessment of the role of surgery for stage III bronchogenic carcinoma</title><author>Hara, Nobuyuki ; Ohta, Mitsuo ; Tanaka, Koichi ; Ichinose, Yukihito ; Noge, Sazahito ; Miyazaki, Kazuhiro ; Ishimatsu, Toyohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4074-38d12fd31c535a208b8e0cb7ef3b92a21204364110fcfc4ac9976d4159b53aa13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - surgery</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Bronchogenic - mortality</topic><topic>Carcinoma, Bronchogenic - surgery</topic><topic>Carcinoma, Small Cell - mortality</topic><topic>Carcinoma, Small Cell - surgery</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Combined Modality Therapy</topic><topic>complete resection</topic><topic>exploratory thoracotomy</topic><topic>Humans</topic><topic>inoperable carcinoma</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - surgery</topic><topic>Medical sciences</topic><topic>Palliative Care</topic><topic>palliative resection</topic><topic>Pneumology</topic><topic>Pneumonectomy</topic><topic>Prognosis</topic><topic>stage III bronchogenic carcinoma</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hara, Nobuyuki</creatorcontrib><creatorcontrib>Ohta, Mitsuo</creatorcontrib><creatorcontrib>Tanaka, Koichi</creatorcontrib><creatorcontrib>Ichinose, Yukihito</creatorcontrib><creatorcontrib>Noge, Sazahito</creatorcontrib><creatorcontrib>Miyazaki, Kazuhiro</creatorcontrib><creatorcontrib>Ishimatsu, Toyohiro</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hara, Nobuyuki</au><au>Ohta, Mitsuo</au><au>Tanaka, Koichi</au><au>Ichinose, Yukihito</au><au>Noge, Sazahito</au><au>Miyazaki, Kazuhiro</au><au>Ishimatsu, Toyohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the role of surgery for stage III bronchogenic carcinoma</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J. Surg. Oncol</addtitle><date>1984-03</date><risdate>1984</risdate><volume>25</volume><issue>3</issue><spage>153</spage><epage>158</epage><pages>153-158</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><coden>JSONAU</coden><abstract>In order to assess the role of surgery for stage III bronchogenic carcinoma, we reviewed our results of 282 patients who were treated with surgical resection or various other therapy modalities. The survival in patients who underwent surgical resection was significantly better than those with nonresectable carcinoma. However, superior survival results were demonstrated only in patients with complete resection. In contrast, the survival in patients with palliative resection was similar to that in patients with exploratory thoracotomy and inoperable carcinoma. On the other hand, all patients with T3N2 lesions died of their disease within two years after surgery even when undergoing complete resection. Thus, we conclude that radical resection should be indicated in patients with T3N0–1 and Tl–2N2 lesions if complete resection is expected.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6199621</pmid><doi>10.1002/jso.2930250304</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-4790 |
| ispartof | Journal of surgical oncology, 1984-03, Vol.25 (3), p.153-158 |
| issn | 0022-4790 1096-9098 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80984584 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adenocarcinoma - mortality Adenocarcinoma - surgery Biological and medical sciences Carcinoma, Bronchogenic - mortality Carcinoma, Bronchogenic - surgery Carcinoma, Small Cell - mortality Carcinoma, Small Cell - surgery Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - surgery Combined Modality Therapy complete resection exploratory thoracotomy Humans inoperable carcinoma Lung Neoplasms - mortality Lung Neoplasms - surgery Medical sciences Palliative Care palliative resection Pneumology Pneumonectomy Prognosis stage III bronchogenic carcinoma Tumors of the respiratory system and mediastinum |
| title | Assessment of the role of surgery for stage III bronchogenic carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T02%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20role%20of%20surgery%20for%20stage%20III%20bronchogenic%20carcinoma&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Hara,%20Nobuyuki&rft.date=1984-03&rft.volume=25&rft.issue=3&rft.spage=153&rft.epage=158&rft.pages=153-158&rft.issn=0022-4790&rft.eissn=1096-9098&rft.coden=JSONAU&rft_id=info:doi/10.1002/jso.2930250304&rft_dat=%3Cproquest_cross%3E80984584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80984584&rft_id=info:pmid/6199621&rfr_iscdi=true |